Almost a year after receiving regulatory approval from the FDA, Competitive Technologies of Fairfield, CT has finally launched its Calmare electrical nerve stimulator via a specially established firm, Calmar Pain Relief, LLC (North Providence, RI). The device, indicated for drug resistant pain management, uses external electric stimulation to manipulate the signals flowing to the central nervous system.
From the product page:
When receiving Calmar Pain Relief Therapy (CPR-T), artificial neurons are created to non-invasively transmit to the central nervous system (CNS) information that is recognizable as ‘self’ and ‘non-pain’ through surface receptors on the skin.
Compared to conventional electro-analgesia, the CPR-T principle substitutes pain information with synthetic ‘non-pain’ information, rather than blocking pain transmission as with TENS or implanted devices utilizing the Gate Control theory. The device incorporates electromedical equipment for electronic nerve stimulation, and uses the nerve fiber as a passive means to convey a message of normality to the central nervous system by a procedure defined as “Scrambling” or tricking of information, which then enables the central nervous system to modify the reflex adaptive responses.
Since the device consists of a multiprocessor apparatus able to simulate five artificial neurons, it allows five pain areas to be treated simultaneously.
Press release: Competitive Technologies Commercially Launches Pain Management Medical Device in U.S….
Product page: CALMARE Therapy Treatment…
Calmar Pain Relief, LLC…
Flashback: Electrical Nerve Stimulator for Drug Resistant Pain Gets Green Light in U.S.